Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2024 15:18 ET | Source: FemPulse

FemPulse Receives FDA IDE Approval for the Pivotal Clinical Trial of its Wearable Bioelectronic Device for Overactive Bladder in Women

SAN FRANCISO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FemPulse™ announced today Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin its EVANESCE II...
January 06, 2020 09:00 ET | Source: FemPulse

FemPulse Announces Issuance of Patents in China and Australia

MINNEAPOLIS, Jan. 06, 2020 (GLOBE NEWSWIRE) -- FemPulse Corporation (FemPulse), a private, clinical-stage bioelectronic medicine company developing a novel therapy for the personalized treatment of...
December 05, 2019 09:00 ET | Source: FemPulse

FemPulse Secures Equity Financing to Finalize Development of Proprietary Bioelectronic Device for Treatment of Overactive Bladder in Women

MINNEAPOLIS, Dec. 05, 2019 (GLOBE NEWSWIRE) -- FemPulse Corporation (FemPulse), a private, clinical-stage bioelectronic medicine company developing a novel therapy for the personalized treatment of...
July 15, 2019 09:00 ET | Source: FemPulse

FemPulse Announces Enrollment of First Participant in Clinical Study for Personalized Treatment of Overactive Bladder (OAB) in Women

MINNEAPOLIS, July 15, 2019 (GLOBE NEWSWIRE) -- FemPulse Corporation (FemPulse), a private, clinical-stage bioelectronic medicine company developing a novel therapy for the personalized treatment of...
March 26, 2019 09:01 ET | Source: FemPulse

FemPulse to Participate in Panel Discussion at the 2019 Bioelectronic Medicine Forum

MINNEAPOLIS, March 26, 2019 (GLOBE NEWSWIRE) -- FemPulse Corporation (FemPulse), a private, clinical-stage bioelectronic medicine company developing a novel therapy for the personalized treatment of...
March 05, 2019 09:00 ET | Source: FemPulse

FemPulse Appoints Dr. Robert Kieval as Chief Scientific and Clinical Officer

MINNEAPOLIS, March 05, 2019 (GLOBE NEWSWIRE) -- FemPulse Corporation (FemPulse), a private, clinical-stage bioelectronic medicine company developing a novel therapy for the personalized treatment of...
February 25, 2019 09:00 ET | Source: FemPulse

FemPulse Announces Enrollment in Multi-Center EVANESCE-OAB Study

MINNEAPOLIS, Feb. 25, 2019 (GLOBE NEWSWIRE) -- FemPulse Corporation (FemPulse), a private, clinical-stage bioelectronic medicine company developing a novel therapy for the personalized treatment of...

Latest News and Press Releases

Search Results

Search Filters